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Summary
Paget’s disease of bone is a focal disorder of the skeleton
whose presentation is variable. Although skeletal deformities
and bone pain may be features of the disease, the diagnosis
frequently is determined by chance. Unexpected elevations of
serum alkaline phosphatase activity and clinically silent lesions
found on X-rays or other imaging modalities are a common
source of discovery of the problem. X-ray appearance of the le-
sion is usually sufficient for diagnosis and a bone biopsy is
rarely necessary to determine the nature of the pathology.
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Introduction
Paget’s disease of bone is a skeletal disorder usually diag-
nosed in patients over the age of 50 years whose clinical pre-
sentation is highly variable. It may be suspected based on
physical examination alone but more commonly is brought to
attention by unexpected radiological or biochemical findings
when an individual is under evaluation for another purpose.
Signs and symptoms
Deformity
A hallmark of Paget’s disease is the presence of one or more
skeletal deformities (1). The most readily apparent, but some-
times subtle, is enlargement of the skull (Figure 1). This usually
produces somewhat asymmetric enlargement of the cranium.
In individuals who wear hats a history of a slow increase in hat
size may be volunteered or mentioned in answer to a direct
question. Hearing loss has been noted in 40-50% of patients
with skull involvement and is more common with skull enlarge-
ment. The degree of hearing loss is often sufficient to require
the use of one or two hearing aids. Tinnitus, vertigo, or both
has been reported in about 20% of patients (2).
The lower extremity is another area which may call attention to
the presence of Paget’s disease. Gradual bowing of either the
femur, the tibia, or occasionally both may proceed so slowly that
even the patient may not be aware of the problem. Bowing of a
lower extremity bone is usually unilateral and when bilateral can
produce a major impairment in ambulation. With increasing
severity of the bowing degenerative changes in the articular car-
tilage of hips, knees, or even ankles may be accelerated. On
physical examination this is manifested most obviously in the
hip as evidenced by reduced range of motion. Two other fea-
tures of Paget’s disease of the lower extremity are a discern-
able enlargement of an affected bone and increased skin tem-
perature over the affected bone. This may be associated with
enlargement of superficial veins in the region. Edema is occa-
sionally noted, but is more likely related to varicose veins. The
increased skin temperature reflects the increased vascularity of
the underlying bone and concomitant increased blood flow to
the surrounding soft tissue (3). This finding is easily reversed by
treatment of Paget’s disease with effective drugs. Suppression
of disease activity reduces vascularity of pagetic lesions.
Less commonly enlargement and deformity may be noted in a
clavicle or upper extremity long bone. Patients with Paget’s dis-
ease may have kyphosis or scoliosis of the spine but the discern-
ment of enlarged vertebrae by physical examination is difficult. 
Bone pain
Bone pain is considered a prominent feature of Paget’s dis-
ease, although it is present in a minority of patients. The bone
pain associated with Paget’s disease is generally persistent,
moderate in severity, and only slightly increased by weight
bearing. Patients with pain are more likely to have degenera-
tive arthritis as the cause. In the absence of physical features
of Paget’s disease, bone pain is useful in the detection of the
disease by directing the appropriate region of the skeleton to
undergo radiological evaluation.
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Figure 1 - Enlarged skull in a man with deafness who has Paget’s dis-
ease.














In 1929 Kay reported that patients with Paget’s disease have
considerable elevation of serum alkaline phosphatase activity
(4), an enzyme found in the plasma membrane of osteoblasts.
Subsequently this test has become the most widely used for
judging the extent and activity of the disease. Because serum
alkaline phosphatase activity has been commonly part of rou-
tine chemistry panels since the 1960’s, the finding of an elevat-
ed level as part of an annual physical examination is a not un-
usual presentation of Paget’s disease. However, the finding of
an isolated elevated alkaline phosphatase in the absence of
typical physical features of Paget’s disease is not sufficient for
diagnosis. This requires radiological evaluation, generally be-
gun with a bone scan surveying the entire skeleton.
Other markers of bone formation, such as bone specific alka-
line phosphatase, and type I procollagen, carboxylterminal
peptide, may be elevated in patients with Paget’s disease (5),
but these tests are not nearly ordered to the same extent as
serum total alkaline phosphatase activity in clinical practice.
As the primary underlying abnormality in Paget’s disease is in-
creased osteoclastic activity, parameters of bone resorption
are commonly elevated in serum and/or urine of most patients.
These include hydroxyproline, N- and C- telopeptides of type I
collagen (5) and pyridinolines. As before, none of these tests
are ordered as frequently as serum total alkaline phosphatase
activity, so that an index of bone resorption would be unusual
in calling attention to Paget’s disease.
Radiology
In the great majority of patients with Paget’s disease the diag-
nosis is made by X-ray evaluation of the affected region(s) of
the skeleton. Although the lesions may be complex, comprised
of osteolytic, osteosclerotic and/or mixed abnormalities, experi-
enced evaluators of bone usually have little difficulty in distin-
guishing the characteristics of Paget’s disease from other dis-
orders (6). Occasionally it may be difficult to distinguish Paget’s
disease from disorders such as osteoblastic metastases or fi-
brous dysplasia. In these instances other clinical features, such
as an elevated serum prostate specific antigen level or an en-
docrine disorder found in McCune-Albright syndrome, respec-
tively, may aid in assuring the appropriate diagnosis. In only a
few cases is a bone biopsy necessary to confirm a diagnosis of
Paget’s disease.
The earliest lesions of Paget’s disease are osteolytic in nature,
and are most likely to be detected in the skull and long bones.
In the skull the lesions are most frequently seen in the frontal
and occipital bones (Figure 2). In the long bones, most fre-
quently in the lower extremities, the lesions generally begin at
the ends of the bones, rarely in the diaphysis. In patients who
are untreated, the osteolytic process has been measured to
progress at a rate of about 1 cm per year.
Osteosclerotic bone appears to be present in areas which pre-
viously were osteolytic in nature. This is readily seen in the
long bones where osteolytic lesions in the shape of an arrow-
head may be seen to evolve from an area of sclerotic bone
(Figure 3). Another typical feature of the osteosclerotic bone is
an increase in the dimensions of the bone.
In the most advanced stage of the disease an entire bone be-
comes sclerotic and often considerably increased in size. This
is readily seen in radiographs of the skull (Figure 4). It should
be noted that, if there is concomitant severe osteoporosis, ex-
tensive osteosclerosis may be overlooked.
It is not uncommon to discover Paget’s disease when X-rays
are done for another purpose. Silent Paget’s disease may be
noted in vertebrae during an intravenous pyelogram or during a
small bowel series. Occasionally, Paget’s disease may be
found when computerized tomography or magnetic resonance
imaging are ordered as part of a medical workup.
Bone scans which utilize a technetium 99m-labeled bisphos-
phonate are the most sensitive means of detecting Paget’s dis-
ease (7), although X-rays are required to validate the diagno-
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Figure 2 - Osteolytic lesions (arrows) in the frontal and occipital regions
of the skull in a woman with Paget’s disease.
Figure 3 - Advancing osteolytic lesions (arrows) which evolved from













sis. In some patients the osteolytic lesions of Paget’s disease
are barely discernable on standard X-rays while the bone scan
indicates avid uptake of tracer by the lesion (Figure 5 A-B).
Rarely, sclerotic lesions on X-ray have no tracer uptake, pre-
sumably reflecting burned out metabolic activity of the disease.  
The role of bone biopsies
Since the X-ray appearance of a skeletal lesion is almost al-
ways sufficient to determine a diagnosis of Paget’s disease it is
seldom necessary to obtain a bone biopsy. This may prove
necessary when even an experienced interpretor of skeletal X-
rays is uncertain of the diagnosis. This might occur when a
solitary osteolytic lesion is detected in the diaphysis of a long
bone rather than at either end. Biopsies are certainly indicated
when there is evidence of disruption of the cortex, a finding
which may indicate a malignant lesion is present.
The pathology of active Paget’s disease is characterized by the
presence of numerous osteoblasts and large multinucleated
osteoclasts, considerable woven bone and a fibrovascular
bone marrow (8). The presence of these findings should ex-
clude all other bone disorders.
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Figure 4 - Osteosclerotic skull of a woman with Paget’s disease. Note
the thickened cranium and the “cotton-wool” appearance in some ar-
eas.
Figure 5 - A. subtle osteolytic lesion of the proximal femur in a 43 year
old woman with Paget’s disease which was not seen on anterior-poste-
rior view of this area. B. Bone scan in the 43 year old woman with
Paget’s disease with increased uptake in the skull, one lumbar verte-
bra, the pelvis and in the proximal femur in the area of the lesion in 5A. 
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